Compare IMTX & FBYDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMTX | FBYDP |
|---|---|---|
| Founded | N/A | N/A |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 992.8M | 1.1B |
| IPO Year | 2020 | 2023 |
| Metric | IMTX | FBYDP |
|---|---|---|
| Price | $6.21 | $5.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $15.97 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 2.2K |
| Earning Date | 11-10-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $14,896,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $14.22 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 120.85 |
| 52 Week Low | $6.07 | $4.60 |
| 52 Week High | $12.41 | $9.71 |
| Indicator | IMTX | FBYDP |
|---|---|---|
| Relative Strength Index (RSI) | 33.37 | 39.62 |
| Support Level | N/A | $4.60 |
| Resistance Level | $7.95 | $7.95 |
| Average True Range (ATR) | 0.46 | 0.47 |
| MACD | -0.02 | -0.23 |
| Stochastic Oscillator | 8.26 | 40.92 |
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.